Global Cancer Ablation Devices Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Cancer Ablation Devices will have significant change from previous year. By the most conservative estimates of global Cancer Ablation Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Cancer Ablation Devices market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Ablation Devices market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Cancer Ablation Devices, covering the supply chain analysis, impact assessment to the Cancer Ablation Devices market size growth rate in several scenarios, and the measures to be undertaken by Cancer Ablation Devices companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Cryoablation
High-Intensity Focused Ultrasound (HIFU)
Laser Interstitial Thermal Therapy (LiTT)
Microwave Ablation (MWA)
Radiofrequency Ablation (RFA)
Irreversible Electroporation (Ire)
Non-Thermal Ablation
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Brain Cancer
Brown
Colorectal Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Alfresa Pharma Corp.
HS Hospital Service S.p.A.
AngioDynamics, Inc.
Biomedical S.r.l.
Boston Scientific Corporation
BTG plc (Galil Medical Ltd./Perseon Medical)
ECO Medical
CSA Medical, Inc.
EDAP TMS S.A.
Chongqing Haifu Medical Technology Co., Ltd
IceCure Medical, Inc.
MedLink Technologies LLC
Kang-Yu Medical Co., Ltd.
MedWaves, Inc.
Johnson & Johnson (Ethicon, Inc.)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cancer Ablation Devices consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cancer Ablation Devices market by identifying its various subsegments.
Focuses on the key global Cancer Ablation Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Ablation Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cancer Ablation Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Cancer Ablation Devices?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Cancer Ablation Devices Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Ablation Devices Consumption 2015-2025
2.1.2 Cancer Ablation Devices Consumption CAGR by Region
2.2 Cancer Ablation Devices Segment by Type
2.2.1 Cryoablation
2.2.2 High-Intensity Focused Ultrasound (HIFU)
2.2.3 Laser Interstitial Thermal Therapy (LiTT)
2.2.4 Microwave Ablation (MWA)
2.2.5 Radiofrequency Ablation (RFA)
2.2.6 Irreversible Electroporation (Ire)
2.2.7 Non-Thermal Ablation
2.3 Cancer Ablation Devices Consumption by Type
2.3.1 Global Cancer Ablation Devices Consumption Market Share by Type (2015-2020)
2.3.2 Global Cancer Ablation Devices Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cancer Ablation Devices Sale Price by Type (2015-2020)
2.4 Cancer Ablation Devices Segment by Application
2.4.1 Brain Cancer
2.4.2 Brown
2.4.3 Colorectal Cancer
2.4.4 Kidney Cancer
2.4.5 Liver Cancer
2.4.6 Lung Cancer
2.4.7 Pancreatic Cancer
2.4.8 Prostate Cancer
2.5 Cancer Ablation Devices Consumption by Application
2.5.1 Global Cancer Ablation Devices Consumption Market Share by Type (2015-2020)
2.5.2 Global Cancer Ablation Devices Value and Market Share by Type (2015-2020)
2.5.3 Global Cancer Ablation Devices Sale Price by Type (2015-2020)
3 Global Cancer Ablation Devices by Company
3.1 Global Cancer Ablation Devices Sales Market Share by Company
3.1.1 Global Cancer Ablation Devices Sales by Company (2018-2020)
3.1.2 Global Cancer Ablation Devices Sales Market Share by Company (2018-2020)
3.2 Global Cancer Ablation Devices Revenue Market Share by Company
3.2.1 Global Cancer Ablation Devices Revenue by Company (2018-2020)
3.2.2 Global Cancer Ablation Devices Revenue Market Share by Company (2018-2020)
3.3 Global Cancer Ablation Devices Sale Price by Company
3.4 Global Cancer Ablation Devices Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cancer Ablation Devices Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cancer Ablation Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cancer Ablation Devices by Regions
4.1 Cancer Ablation Devices by Regions
4.2 Americas Cancer Ablation Devices Consumption Growth
4.3 APAC Cancer Ablation Devices Consumption Growth
4.4 Europe Cancer Ablation Devices Consumption Growth
4.5 Middle East & Africa Cancer Ablation Devices Consumption Growth
5 Americas
5.1 Americas Cancer Ablation Devices Consumption by Countries
5.1.1 Americas Cancer Ablation Devices Consumption by Countries (2015-2020)
5.1.2 Americas Cancer Ablation Devices Value by Countries (2015-2020)
5.2 Americas Cancer Ablation Devices Consumption by Type
5.3 Americas Cancer Ablation Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cancer Ablation Devices Consumption by Regions
6.1.1 APAC Cancer Ablation Devices Consumption by Regions (2015-2020)
6.1.2 APAC Cancer Ablation Devices Value by Regions (2015-2020)
6.2 APAC Cancer Ablation Devices Consumption by Type
6.3 APAC Cancer Ablation Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cancer Ablation Devices by Countries
7.1.1 Europe Cancer Ablation Devices Consumption by Countries (2015-2020)
7.1.2 Europe Cancer Ablation Devices Value by Countries (2015-2020)
7.2 Europe Cancer Ablation Devices Consumption by Type
7.3 Europe Cancer Ablation Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cancer Ablation Devices by Countries
8.1.1 Middle East & Africa Cancer Ablation Devices Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cancer Ablation Devices Value by Countries (2015-2020)
8.2 Middle East & Africa Cancer Ablation Devices Consumption by Type
8.3 Middle East & Africa Cancer Ablation Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cancer Ablation Devices Distributors
10.3 Cancer Ablation Devices Customer
11 Global Cancer Ablation Devices Market Forecast
11.1 Global Cancer Ablation Devices Consumption Forecast (2021-2025)
11.2 Global Cancer Ablation Devices Forecast by Regions
11.2.1 Global Cancer Ablation Devices Forecast by Regions (2021-2025)
11.2.2 Global Cancer Ablation Devices Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cancer Ablation Devices Forecast by Type
11.8 Global Cancer Ablation Devices Forecast by Application
12 Key Players Analysis
12.1 Alfresa Pharma Corp.
12.1.1 Company Information
12.1.2 Cancer Ablation Devices Product Offered
12.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Alfresa Pharma Corp. Latest Developments
12.2 HS Hospital Service S.p.A.
12.2.1 Company Information
12.2.2 Cancer Ablation Devices Product Offered
12.2.3 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 HS Hospital Service S.p.A. Latest Developments
12.3 AngioDynamics, Inc.
12.3.1 Company Information
12.3.2 Cancer Ablation Devices Product Offered
12.3.3 AngioDynamics, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 AngioDynamics, Inc. Latest Developments
12.4 Biomedical S.r.l.
12.4.1 Company Information
12.4.2 Cancer Ablation Devices Product Offered
12.4.3 Biomedical S.r.l. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Biomedical S.r.l. Latest Developments
12.5 Boston Scientific Corporation
12.5.1 Company Information
12.5.2 Cancer Ablation Devices Product Offered
12.5.3 Boston Scientific Corporation Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Boston Scientific Corporation Latest Developments
12.6 BTG plc (Galil Medical Ltd./Perseon Medical)
12.6.1 Company Information
12.6.2 Cancer Ablation Devices Product Offered
12.6.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 BTG plc (Galil Medical Ltd./Perseon Medical) Latest Developments
12.7 ECO Medical
12.7.1 Company Information
12.7.2 Cancer Ablation Devices Product Offered
12.7.3 ECO Medical Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 ECO Medical Latest Developments
12.8 CSA Medical, Inc.
12.8.1 Company Information
12.8.2 Cancer Ablation Devices Product Offered
12.8.3 CSA Medical, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 CSA Medical, Inc. Latest Developments
12.9 EDAP TMS S.A.
12.9.1 Company Information
12.9.2 Cancer Ablation Devices Product Offered
12.9.3 EDAP TMS S.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 EDAP TMS S.A. Latest Developments
12.10 Chongqing Haifu Medical Technology Co., Ltd
12.10.1 Company Information
12.10.2 Cancer Ablation Devices Product Offered
12.10.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Chongqing Haifu Medical Technology Co., Ltd Latest Developments
12.11 IceCure Medical, Inc.
12.11.1 Company Information
12.11.2 Cancer Ablation Devices Product Offered
12.11.3 IceCure Medical, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 IceCure Medical, Inc. Latest Developments
12.12 MedLink Technologies LLC
12.12.1 Company Information
12.12.2 Cancer Ablation Devices Product Offered
12.12.3 MedLink Technologies LLC Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 MedLink Technologies LLC Latest Developments
12.13 Kang-Yu Medical Co., Ltd.
12.13.1 Company Information
12.13.2 Cancer Ablation Devices Product Offered
12.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Kang-Yu Medical Co., Ltd. Latest Developments
12.14 MedWaves, Inc.
12.14.1 Company Information
12.14.2 Cancer Ablation Devices Product Offered
12.14.3 MedWaves, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 MedWaves, Inc. Latest Developments
12.15 Johnson & Johnson (Ethicon, Inc.)
12.15.1 Company Information
12.15.2 Cancer Ablation Devices Product Offered
12.15.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Johnson & Johnson (Ethicon, Inc.) Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Cancer Ablation Devices Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Cancer Ablation Devices Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Cancer Ablation Devices Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Cryoablation
Table 7. Major Players of High-Intensity Focused Ultrasound (HIFU)
Table 8. Major Players of Laser Interstitial Thermal Therapy (LiTT)
Table 9. Major Players of Microwave Ablation (MWA)
Table 10. Major Players of Radiofrequency Ablation (RFA)
Table 11. Major Players of Irreversible Electroporation (Ire)
Table 12. Major Players of Non-Thermal Ablation
Table 13. Global Consumption Sales by Type (2015-2020)
Table 14. Global Cancer Ablation Devices Consumption Market Share by Type (2015-2020)
Table 15. Global Cancer Ablation Devices Revenue by Type (2015-2020) ($ million)
Table 16. Global Cancer Ablation Devices Value Market Share by Type (2015-2020) ($ Millions)
Table 17. Global Cancer Ablation Devices Sale Price by Type (2015-2020)
Table 18. Global Consumption Sales by Application (2015-2020)
Table 19. Global Cancer Ablation Devices Consumption Market Share by Application (2015-2020)
Table 20. Global Cancer Ablation Devices Value by Application (2015-2020)
Table 21. Global Cancer Ablation Devices Value Market Share by Application (2015-2020)
Table 22. Global Cancer Ablation Devices Sale Price by Application (2015-2020)
Table 23. Global Cancer Ablation Devices Sales by Company (2017-2019) (K Units)
Table 24. Global Cancer Ablation Devices Sales Market Share by Company (2017-2019)
Table 25. Global Cancer Ablation Devices Revenue by Company (2017-2019) ($ Millions)
Table 26. Global Cancer Ablation Devices Revenue Market Share by Company (2017-2019)
Table 27. Global Cancer Ablation Devices Sale Price by Company (2017-2019)
Table 28. Global Cancer Ablation Devices Manufacturing Base Distribution and Sales Area by Manufacturers
Table 29. Players Cancer Ablation Devices Products Offered
Table 30. Cancer Ablation Devices Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 31. Global Cancer Ablation Devices Consumption by Regions 2015-2020 (K Units)
Table 32. Global Cancer Ablation Devices Consumption Market Share by Regions 2015-2020
Table 33. Global Cancer Ablation Devices Value by Regions 2015-2020 ($ Millions)
Table 34. Global Cancer Ablation Devices Value Market Share by Regions 2015-2020
Table 35. Americas Cancer Ablation Devices Consumption by Countries (2015-2020) (K Units)
Table 36. Americas Cancer Ablation Devices Consumption Market Share by Countries (2015-2020)
Table 37. Americas Cancer Ablation Devices Value by Countries (2015-2020) ($ Millions)
Table 38. Americas Cancer Ablation Devices Value Market Share by Countries (2015-2020)
Table 39. Americas Cancer Ablation Devices Consumption by Type (2015-2020) (K Units)
Table 40. Americas Cancer Ablation Devices Consumption Market Share by Type (2015-2020)
Table 41. Americas Cancer Ablation Devices Consumption by Application (2015-2020) (K Units)
Table 42. Americas Cancer Ablation Devices Consumption Market Share by Application (2015-2020)
Table 43. APAC Cancer Ablation Devices Consumption by Countries (2015-2020) (K Units)
Table 44. APAC Cancer Ablation Devices Consumption Market Share by Countries (2015-2020)
Table 45. APAC Cancer Ablation Devices Value by Regions (2015-2020) ($ Millions)
Table 46. APAC Cancer Ablation Devices Value Market Share by Regions (2015-2020)
Table 47. APAC Cancer Ablation Devices Consumption by Type (2015-2020) (K Units)
Table 48. APAC Cancer Ablation Devices Consumption Market Share by Type (2015-2020)
Table 49. APAC Cancer Ablation Devices Consumption by Application (2015-2020) (K Units)
Table 50. APAC Cancer Ablation Devices Consumption Market Share by Application (2015-2020)
Table 51. Europe Cancer Ablation Devices Consumption by Countries (2015-2020) (K Units)
Table 52. Europe Cancer Ablation Devices Consumption Market Share by Countries (2015-2020)
Table 53. Europe Cancer Ablation Devices Value by Countries (2015-2020) ($ Millions)
Table 54. Europe Cancer Ablation Devices Value Market Share by Countries (2015-2020)
Table 55. Europe Cancer Ablation Devices Consumption by Type (2015-2020) (K Units)
Table 56. Europe Cancer Ablation Devices Consumption Market Share by Type (2015-2020)
Table 57. Europe Cancer Ablation Devices Consumption by Application (2015-2020) (K Units)
Table 58. Europe Cancer Ablation Devices Consumption Market Share by Application (2015-2020)
Table 59. Middle East & Africa Cancer Ablation Devices Consumption by Countries (2015-2020) (K Units)
Table 60. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Countries (2015-2020)
Table 61. Middle East & Africa Cancer Ablation Devices Value by Countries (2015-2020) ($ Millions)
Table 62. Middle East & Africa Cancer Ablation Devices Value Market Share by Countries (2015-2020)
Table 63. Middle East & Africa Cancer Ablation Devices Consumption by Type (2015-2020) (K Units)
Table 64. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Type (2015-2020)
Table 65. Middle East & Africa Cancer Ablation Devices Consumption by Application (2015-2020) (K Units)
Table 66. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Application (2015-2020)
Table 67. Cancer Ablation Devices Distributors List
Table 68. Cancer Ablation Devices Customer List
Table 69. Global Cancer Ablation Devices Consumption Forecast by Countries (2021-2025) (K Units)
Table 70. Global Cancer Ablation Devices Consumption Market Forecast by Regions
Table 71. Global Cancer Ablation Devices Value Forecast by Countries (2021-2025) ($ Millions)
Table 72. Global Cancer Ablation Devices Value Market Share Forecast by Regions
Table 73. Global Cancer Ablation Devices Consumption Forecast by Type (2021-2025) (K Units)
Table 74. Global Cancer Ablation Devices Consumption Market Share Forecast by Type (2021-2025)
Table 75. Global Cancer Ablation Devices Value Forecast by Type (2021-2025) ($ Millions)
Table 76. Global Cancer Ablation Devices Value Market Share Forecast by Type (2021-2025)
Table 77. Global Cancer Ablation Devices Consumption Forecast by Application (2021-2025) (K Units)
Table 78. Global Cancer Ablation Devices Consumption Market Share Forecast by Application (2021-2025)
Table 79. Global Cancer Ablation Devices Value Forecast by Application (2021-2025) ($ Millions)
Table 80. Global Cancer Ablation Devices Value Market Share Forecast by Application (2021-2025)
Table 81. Alfresa Pharma Corp. Product Offered
Table 82. Alfresa Pharma Corp. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Alfresa Pharma Corp. Main Business
Table 84. Alfresa Pharma Corp. Latest Developments
Table 85. Alfresa Pharma Corp. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 86. HS Hospital Service S.p.A. Product Offered
Table 87. HS Hospital Service S.p.A. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. HS Hospital Service S.p.A. Main Business
Table 89. HS Hospital Service S.p.A. Latest Developments
Table 90. HS Hospital Service S.p.A. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 91. AngioDynamics, Inc. Product Offered
Table 92. AngioDynamics, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. AngioDynamics, Inc. Main Business
Table 94. AngioDynamics, Inc. Latest Developments
Table 95. AngioDynamics, Inc. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 96. Biomedical S.r.l. Product Offered
Table 97. Biomedical S.r.l. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Biomedical S.r.l. Main Business
Table 99. Biomedical S.r.l. Latest Developments
Table 100. Biomedical S.r.l. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 101. Boston Scientific Corporation Product Offered
Table 102. Boston Scientific Corporation Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Boston Scientific Corporation Main Business
Table 104. Boston Scientific Corporation Latest Developments
Table 105. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 106. BTG plc (Galil Medical Ltd./Perseon Medical) Product Offered
Table 107. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 108. BTG plc (Galil Medical Ltd./Perseon Medical) Main Business
Table 109. BTG plc (Galil Medical Ltd./Perseon Medical) Latest Developments
Table 110. BTG plc (Galil Medical Ltd./Perseon Medical) Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 111. ECO Medical Product Offered
Table 112. ECO Medical Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. ECO Medical Main Business
Table 114. ECO Medical Latest Developments
Table 115. ECO Medical Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. CSA Medical, Inc. Product Offered
Table 117. CSA Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. CSA Medical, Inc. Main Business
Table 119. CSA Medical, Inc. Latest Developments
Table 120. CSA Medical, Inc. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 121. EDAP TMS S.A. Product Offered
Table 122. EDAP TMS S.A. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. EDAP TMS S.A. Main Business
Table 124. EDAP TMS S.A. Latest Developments
Table 125. EDAP TMS S.A. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 126. Chongqing Haifu Medical Technology Co., Ltd Product Offered
Table 127. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Chongqing Haifu Medical Technology Co., Ltd Main Business
Table 129. Chongqing Haifu Medical Technology Co., Ltd Latest Developments
Table 130. Chongqing Haifu Medical Technology Co., Ltd Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors
Table 131. IceCure Medical, Inc. Product Offered
Table 132. IceCure Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. IceCure Medical, Inc. Main Business
Table 134. IceCure Medical, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. IceCure Medical, Inc. Latest Developments
Table 136. MedLink Technologies LLC Product Offered
Table 137. MedLink Technologies LLC Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. MedLink Technologies LLC Main Business
Table 139. MedLink Technologies LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. MedLink Technologies LLC Latest Developments
Table 141. Kang-Yu Medical Co., Ltd. Product Offered
Table 142. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 143. Kang-Yu Medical Co., Ltd. Main Business
Table 144. Kang-Yu Medical Co., Ltd. Latest Developments
Table 145. Kang-Yu Medical Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. MedWaves, Inc. Product Offered
Table 147. MedWaves, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 148. MedWaves, Inc. Main Business
Table 149. MedWaves, Inc. Latest Developments
Table 150. MedWaves, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Johnson & Johnson (Ethicon, Inc.) Product Offered
Table 152. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 153. Johnson & Johnson (Ethicon, Inc.) Main Business
Table 154. Johnson & Johnson (Ethicon, Inc.) Latest Developments
Table 155. Johnson & Johnson (Ethicon, Inc.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cancer Ablation Devices
Figure 2. Cancer Ablation Devices Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cancer Ablation Devices Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Cancer Ablation Devices Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Cryoablation
Figure 7. Product Picture of High-Intensity Focused Ultrasound (HIFU)
Figure 8. Product Picture of Laser Interstitial Thermal Therapy (LiTT)
Figure 9. Product Picture of Microwave Ablation (MWA)
Figure 10. Product Picture of Radiofrequency Ablation (RFA)
Figure 11. Product Picture of Irreversible Electroporation (Ire)
Figure 12. Product Picture of Non-Thermal Ablation
Figure 13. Global Cancer Ablation Devices Consumption Market Share by Type (2015-2020)
Figure 14. Global Cancer Ablation Devices Value Market Share by Type (2015-2020)
Figure 15. Cancer Ablation Devices Consumed in Brain Cancer
Figure 16. Global Cancer Ablation Devices Market: Brain Cancer (2015-2020) (K Units)
Figure 17. Global Cancer Ablation Devices Market: Brain Cancer (2015-2020) ($ Millions)
Figure 18. Cancer Ablation Devices Consumed in Brown
Figure 19. Global Cancer Ablation Devices Market: Brown (2015-2020) (K Units)
Figure 20. Global Cancer Ablation Devices Market: Brown (2015-2020) ($ Millions)
Figure 21. Cancer Ablation Devices Consumed in Colorectal Cancer
Figure 22. Global Cancer Ablation Devices Market: Colorectal Cancer (2015-2020) (K Units)
Figure 23. Global Cancer Ablation Devices Market: Colorectal Cancer (2015-2020) ($ Millions)
Figure 24. Cancer Ablation Devices Consumed in Kidney Cancer
Figure 25. Global Cancer Ablation Devices Market: Kidney Cancer (2015-2020) (K Units)
Figure 26. Global Cancer Ablation Devices Market: Kidney Cancer (2015-2020) ($ Millions)
Figure 27. Cancer Ablation Devices Consumed in Liver Cancer
Figure 28. Global Cancer Ablation Devices Market: Liver Cancer (2015-2020) (K Units)
Figure 29. Global Cancer Ablation Devices Market: Liver Cancer (2015-2020) ($ Millions)
Figure 30. Cancer Ablation Devices Consumed in Lung Cancer
Figure 31. Cancer Ablation Devices Consumed in Pancreatic Cancer
Figure 32. Cancer Ablation Devices Consumed in Prostate Cancer
Figure 33. Global Cancer Ablation Devices Consumption Market Share by Application (2015-2020)
Figure 34. Global Cancer Ablation Devices Value Market Share by Application (2015-2020)
Figure 35. Global Cancer Ablation Devices Sales Market Share by Company in 2017
Figure 36. Global Cancer Ablation Devices Sales Market Share by Company in 2019
Figure 37. Global Cancer Ablation Devices Revenue Market Share by Company in 2017
Figure 38. Global Cancer Ablation Devices Revenue Market Share by Company in 2019
Figure 39. Global Cancer Ablation Devices Sale Price by Company in 2019
Figure 40. Global Cancer Ablation Devices Consumption Market Share by Regions 2015-2020
Figure 41. Global Cancer Ablation Devices Value Market Share by Regions 2015-2020
Figure 42. Americas Cancer Ablation Devices Consumption 2015-2020 (K Units)
Figure 43. Americas Cancer Ablation Devices Value 2015-2020 ($ Millions)
Figure 44. APAC Cancer Ablation Devices Consumption 2015-2020 (K Units)
Figure 45. APAC Cancer Ablation Devices Value 2015-2020 ($ Millions)
Figure 46. Europe Cancer Ablation Devices Consumption 2015-2020 (K Units)
Figure 47. Europe Cancer Ablation Devices Value 2015-2020 ($ Millions)
Figure 48. Middle East & Africa Cancer Ablation Devices Consumption 2015-2020 (K Units)
Figure 49. Middle East & Africa Cancer Ablation Devices Value 2015-2020 ($ Millions)
Figure 50. Americas Cancer Ablation Devices Consumption Market Share by Countries in 2019
Figure 51. Americas Cancer Ablation Devices Value Market Share by Countries in 2019
Figure 52. Americas Cancer Ablation Devices Consumption Market Share by Type in 2019
Figure 53. Americas Cancer Ablation Devices Consumption Market Share by Application in 2019
Figure 54. United States Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 55. United States Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 56. Canada Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 57. Canada Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 58. Mexico Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 59. Mexico Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 60. APAC Cancer Ablation Devices Consumption Market Share by Countries in 2019
Figure 61. APAC Cancer Ablation Devices Value Market Share by Regions in 2019
Figure 62. APAC Cancer Ablation Devices Consumption Market Share by Type in 2019
Figure 63. APAC Cancer Ablation Devices Consumption Market Share by Application in 2019
Figure 64. China Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 65. China Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 66. Japan Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 67. Japan Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 68. Korea Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 69. Korea Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 70. Southeast Asia Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 71. Southeast Asia Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 72. India Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 73. India Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 74. Australia Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 75. Australia Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 76. Europe Cancer Ablation Devices Consumption Market Share by Countries in 2019
Figure 77. Europe Cancer Ablation Devices Value Market Share by Countries in 2019
Figure 78. Europe Cancer Ablation Devices Consumption Market Share by Type in 2019
Figure 79. Europe Cancer Ablation Devices Consumption Market Share by Application in 2019
Figure 80. Germany Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 81. Germany Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 82. France Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 83. France Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 84. UK Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 85. UK Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 86. Italy Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 87. Italy Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 88. Russia Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 89. Russia Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 90. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Countries in 2019
Figure 91. Middle East & Africa Cancer Ablation Devices Value Market Share by Countries in 2019
Figure 92. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Type in 2019
Figure 93. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Application in 2019
Figure 94. Egypt Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 95. Egypt Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 96. South Africa Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 97. South Africa Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 98. Israel Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 99. Israel Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 100. Turkey Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 101. Turkey Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 102. GCC Countries Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)
Figure 103. GCC Countries Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)
Figure 104. Global Cancer Ablation Devices Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 105. Global Cancer Ablation Devices Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 106. Americas Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 107. Americas Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 108. APAC Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 109. APAC Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 110. Europe Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 111. Europe Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 112. Middle East & Africa Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 113. Middle East & Africa Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 114. United States Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 115. United States Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 116. Canada Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 117. Canada Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 118. Mexico Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 119. Mexico Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 120. Brazil Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 121. Brazil Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 122. China Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 123. China Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 124. Japan Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 125. Japan Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 126. Korea Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 127. Korea Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 128. Southeast Asia Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 129. Southeast Asia Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 130. India Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 131. India Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 132. Australia Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 133. Australia Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 134. Germany Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 135. Germany Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 136. France Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 137. France Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 138. UK Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 139. UK Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 140. Italy Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 141. Italy Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 142. Russia Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 143. Russia Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 144. Spain Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 145. Spain Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 146. Egypt Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 147. Egypt Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 148. South Africa Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 149. South Africa Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 150. Israel Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 151. Israel Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 152. Turkey Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 153. Turkey Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 154. GCC Countries Cancer Ablation Devices Consumption 2021-2025 (K Units)
Figure 155. GCC Countries Cancer Ablation Devices Value 2021-2025 ($ Millions)
Figure 156. Alfresa Pharma Corp. Cancer Ablation Devices Market Share (2018-2020)
Figure 157. HS Hospital Service S.p.A. Cancer Ablation Devices Market Share (2018-2020)
Figure 158. AngioDynamics, Inc. Cancer Ablation Devices Market Share (2018-2020)
Figure 159. Biomedical S.r.l. Cancer Ablation Devices Market Share (2018-2020)
Figure 160. Boston Scientific Corporation Cancer Ablation Devices Market Share (2018-2020)
Figure 161. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Market Share (2018-2020)
Figure 162. ECO Medical Cancer Ablation Devices Market Share (2018-2020)
Figure 163. CSA Medical, Inc. Cancer Ablation Devices Market Share (2018-2020)
Figure 164. EDAP TMS S.A. Cancer Ablation Devices Market Share (2018-2020)
Figure 165. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Market Share (2018-2020)
Figure 166. IceCure Medical, Inc. Cancer Ablation Devices Market Share (2018-2020)
Figure 167. MedLink Technologies LLC Cancer Ablation Devices Market Share (2018-2020)
Figure 168. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Market Share (2018-2020)
Figure 169. MedWaves, Inc. Cancer Ablation Devices Market Share (2018-2020)
Figure 170. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Market Share (2018-2020)